Skip to main content
. 2022 Apr 29;75(12):2178–2185. doi: 10.1093/cid/ciac326

Table 1.

Baseline Characteristics of Cases and Controls

Characteristic Case (N = 60) n (%) or Median (IQR) Na Control (N = 251) n (%) or Median (IQR) Na
Age in years 38.0 (31.0–43.5) 60 38.0 (32.0–45.0) 251
Female 33 (55.0) 60 149 (59.4) 251
Living with spouse/partner 28 (46.7) 60 107 (42.6) 251
Education 60 251
 No school 22 (36.7) 72 (28.7)
 Primary school 14 (23.3) 73 (29.1)
 Secondary school or more 24 (40.0) 106 (42.2)
Annual income ≤$129/year 39 (65.0) 60 152 (60.6) 251
History of tuberculosis disease 16 (26.7) 60 38 (15.1) 251
Positive tuberculin skin test (≥5 mm) 22 (44.9) 49 65 (29.0) 224
Body mass index, kg/m2 60 251
 Underweight 15 (25.0) 32 (12.8)
 Overweight 10 (16.7) 37 (14.7)
 Normal 35 (58.3) 182 (72.5)
Use of antiretroviral therapy 58 (96.7) 60 239 (95.2) 251
Human immunodeficiency virus clinical stage 60 251
 1 12 (20.0) 66 (26.3)
 2 32 (53.3) 147 (58.6)
 3 16 (26.7) 38 (15.1)
 4 0 (0.0) 0 (0.0)
Baseline CD4 count (cells/mm3) 282.0 (239.5–311.0) 60 282.0 (255.0–312.0) 251
Baseline hemoglobin (g/dL) 11.5 (10.2–12.5) 60 11.7 (10.6–12.9) 251
Baseline C-reactive protein (ng/mL) 1220.5 (671.3) 60 1352.0 (556.0–3790.0) 245
 Highest tertile 12 728.0 (5590.0–20 957.0) 21 6708.5 (4032.0–10 450.0) 81
 Middle tertile 1129.5 (899.0–1650.0) 23 1417.0 (1095.0–1789.0) 79
 Lowest tertile 299.5 (160.0–359.5) 16 282.0 (158.5–566.0) 85
Vitamin A deficiency (<20 µg/dL) 19 (31.7) 60 21 (8.4) 251

Abbreviation: IQR, interquartile range.

a

Number of participants with data for corresponding variable.